Varices and variceal bleed resident survival guide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Twinkle Singh, M.B.B.S. [2], Rim Halaby, M.D. [3]

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Variceal bleed is a life-threatening condition and must be treated as such irrespective of the causes.

Common Causes

• Cirrhosis

Screening and Management of Non Bleeding Varices in Cirrhosis

❑ Diagnosis of cirrhosis ❑ No evidence of variceal bleed

Screen for varices: ❑ Order an EGD

No varices

Esophageal varices

Gastric varices

Follow up with EGD: ❑ Every 3 years ❑ At the time of any hepatic decompensation, and annually thereafter

Small (<5mm)

Medium/Large (>5mm)

❑ Cyanoacrylate or EVL

❑ Assess risk of hemorrhage

❑ Assess risk of hemorrhage

High†

Low‡

High†

Low‡

❑ Non selective beta blockers should be used

❑ Non selective beta blockers may be used, OR ❑ EGD every 2 years if beta blockers are not used

❑ Non selective beta blockers, OR ❑ EVL

❑ First line: Non selective beta blockers ❑ Second line: EVL

If a patient is treated with EVL: ❑ Repeat EVL every 1-2 weeks until obliteration ❑ Perform a first surveillance EGD 1-3 months after obliteration ❑ Repeat EVL every 6-12 months to check for variceal recurrence

The algorithm is based on the practice guidelines approved by American Association for the Study of Liver Diseases (AASLD) and American College of Gastroenterology (ACG).

† Varices at high risk of bleeding:

• Cirrhosis with Child-Pugh class B or C severity.
• Presence of red wale marks on varices visualized on endoscopy.

‡ Varices not at high risk of bleeding:

• Cirrhosis with Child-Pugh class A severity.
• No red wale marks on varices.

Management of Actively Bleeding Varices

Suspected acute variceal hemorrhage ❑ Patient with known cirrhosis ❑ Coffee ground emesis

General measures: ❑ Admit the patient to ICU ❑ Assess airway ❑ Obtain peripheral venous access ❑ Blood volume resuscitation (maintain a hemoglobin of 8mg/dl) ❑ Elective or emergent tracheal intubation prior to endoscopy ( mainly in case of concomitant hepatic encephalopathy)

Short term prophylactic antibiotics (7 days) ❑ Oral norfloxacin (400mg BID), OR ❑ IV ciprofloxacin (impossible oral administration) ❑ IV ceftriaxone (1g/day) in advanced cirrhosis and in a setting with high prevalence of quinolone resistance

Initiate pharmacological therapy when variceal bleed is suspected, even before confirming the diagnosis by EGD: ❑ Vasopressin (IV infusion 0.2 to 0.4 units/min up to 0.8 units/min)+ Nitroglycerine (IV 40 μg/min, can be increased up to 400 μg/min) adjusted to maintain a systolic blood pressure 90 mmHg, OR ❑ Terlipressin (IV 2 mg every 4 hours titrated down to 1 mg every4 hours)- not available in US- OR ❑ Somatostatin (250 μg IV bolus followed by 250 μg/hr continuous infusion) OR ❑ Octreotide (somatostatin analogue), IV bolus of 50μg followed by continuous infusion 50μg/hour ❑ Continue pharmacological therapy 3-5 days after the diagnosis is confirmed

Perform EGD: ❑ Confirm the diagnosis of variceal bleed (within 12 hours of admission) ASAP Perform endoscopic therapy: ❑ Endoscopic variceal ligation (preferred) ❑ Sclerotherapy (if EVL is not feasible)

Failure to control OR recurrence of variceal bleed despite pharmacological and endoscopic therapy?

Yes ❑ TIPS, OR ❑ Shunt surgery ❑ Balloon tamponade should be used as a temporizing measure (maximum 24 hours) in patients with uncontrollable bleeding for whom a more definitive therapy is planned

No Management following recovery of the patient: ❑ Secondary prophylaxis before discharge (non selective beta blocker + EVL)

No secondary prophylaxis

❑ Refer transplant candidates to a transplant center

The algorithm is based on the practice guidelines approved by American Association for the Study of Liver Diseases (AASLD) and American College of Gastroenterology (ACG).

Do's

• If a patient is placed on beta blocker, its dose should be adjusted to maximum tolerated dose.
• If EVL is done, it should be repeated every 1 to 2 weeks, until varices are completely obliterated. Follow up EGD is done after 1 to 3 months and after that every 6-12 months to look for any recurrence.
• Vasoconstrictive pharmacotherapy (somatostatin, octreotide, vasopressin) should be started as soon as bleeding is suspected from varices and should be continued for 3-5 days after the diagnosis.

Dont's

• In patients with small varices, who are on beta blockers, follow up with EGD is not recommended.
• Beta blockers are not recommended to prevent variceal development in cirrhotic patients with no varices.
• Nitrates, sclerotherapy and shunt therapy should not be used to prevent first variceal bleed.
• Don't use beta blockers in acute bleed because it will cause reflex tachycardia that might worsen bleeding.
• Avoid vigorous resuscitation with saline solution in variceal bleed.